Weiguo Ye, Chief Operating Officer at GYRE THERAPEUTICS, INC. (GYRE), sold 22,220 shares at $6.15 ($137K) on 2026-05-20, disclosed to the SEC on 2026-05-22.
Open-market sale of $137k GYRE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.15 | 9,400 | $58K | 42.3% |
| 2 | $6.15 | 12,820 | $79K | 57.7% |
| Total | $6.15 avg | 22,220 | $137K | 100% |
| Filing → |
| GYRE | SELL | 2026-06-11 | $129K | — | Filing → |
| GYRE | SELL | 2026-06-08 | $219K | — | Filing → |
| GYRE | SELL | 2026-05-27 | $46K | — | Filing → |